{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:11:53Z","timestamp":1787314313406,"version":"build-2736575974"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"878","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,12,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Glaucoma is the third most prevalent cause of global blindness, accounting for over 5 million blind. It is common in Western Countries; the estimated prevalence of primary open angle glaucoma rises from a total prevalence of 1.1% to approximately 3% of our population as it ages. Ethnicity affects both the risk of developing glaucoma and the outcome. It is an expensive disease both to detect and to treat. Recent scientific advances include elucidation of the genetic mechanism behind the disease and the study of haemodynamic and biochemical co-factors in the development of glaucomatous optic neuropathy, particularly in relation to the pathogenesis of normal tension glaucoma. Several new types of topical medication have recently been developed for use in glaucoma; both the impact of these therapies and their cost effectiveness remain to be evaluated.<\/jats:p>\n                  <jats:p>There are widely differing regimes which effectively treat glaucoma; some ophthalmologists prefer early surgical intervention whilst others reserve surgery for relatively advanced disease. All methods of current treatment rely on the reduction of intra-ocular pressure; as yet there is no medication which has been definitively proven to be either neuroprotective or to influence favourably optic nerve perfusion. Despite this, most sufferers of glaucoma are able to lead lives of quality. Increased community awareness of glaucoma, and earlier detection of the condition, will doubtless result in decreased morbidity due to glaucoma.<\/jats:p>","DOI":"10.1136\/pgmj.74.878.709","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T16:49:00Z","timestamp":1230569340000},"page":"709-715","source":"Crossref","is-referenced-by-count":18,"title":["Glaucoma: diagnosis and management"],"prefix":"10.1093","volume":"74","author":[{"given":"D A","family":"Infeld","sequence":"first","affiliation":[{"name":"The Glaucoma Service, Birmingham and Midland Eye Centre , Dudley Rd, Birmingham B18 7QU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J G","family":"O'Shea","sequence":"additional","affiliation":[{"name":"The Glaucoma Service, Birmingham and Midland Eye Centre , Dudley Rd, Birmingham B18 7QU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1998,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-9394(14)70127-8","article-title":"Blood-flow velocities of the extraocular vessels in patients with high-tension and normaltension primary open-angle glaucoma","volume":"123","author":"Kaiser, H.J.; Schoetzau, A.; Stumpfig, D.; Flammer, J.","year":"1997","unstructured":"Kaiser HJ, Schoetzau A, Stumpfig D, Flammer J. Blood-flow velocities of the extraocular vessels in patients with high-tension and normaltension primary open-angle glaucoma. Am J Ophthalmol 1997;123:320-7.","journal-title":"Am J Ophthalmol"},{"key":"ref_2","first-page":"2","article-title":"World distribution of blindness","volume":"1","author":"Foster, A.","year":"1988","unstructured":"Foster A. World distribution of blindness. J Community Eye Health 1988;1:2.","journal-title":"J Community Eye Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7748\/ns.10.11.34.s38","article-title":"Setting up a shared care glaucoma clinic","volume":"lO:","author":"Hume, J.","year":"1995","unstructured":"Hume J. Setting up a shared care glaucoma clinic. Nursing Standard 1995;lO:34-6.","journal-title":"Nursing Standard"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/09286589709058056","article-title":"The cost-effectiveness of various modes of screening for primary open angle glaucoma","volume":"4","author":"Tuck, M.W.; Crick, R.P.","year":"1997","unstructured":"Tuck MW, Crick RP. The cost-effectiveness of various modes of screening for primary open angle glaucoma. Ophthalmic Epidemiol 1997;4: 3-17.","journal-title":"Ophthalmic Epidemiol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.aje.a112428","article-title":"The Framingham Eye study: outline of major prevalence findings","volume":"106","author":"Kahn, H.A.","year":"1977","unstructured":"Kahn HA. The Framingham Eye study: outline of major prevalence findings. Am J Epidemiolog 1977;106: 17-32.","journal-title":"Am J Epidemiolog"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/13816819609057895","article-title":"The problem of overlapping glaucoma families in the Glaucoma Inheritance Study in Tasmania (GIST)","volume":"17","author":"Sack, J.; Healey, D.L.; de Graaf, A.P.","year":"1996","unstructured":"Sack J, Healey DL, de Graaf AP, et al. The problem of overlapping glaucoma families in the Glaucoma Inheritance Study in Tasmania (GIST). Ophthalmic Genet 1996;17:209-14.","journal-title":"Ophthalmic Genet"},{"key":"ref_7","first-page":"1851","article-title":"The prevalence of primary open-angle glaucoma in a populationbased study in The Netherlands","volume":"101","author":"Dielemans, I.; Vingerling, JR, Wolfs; RC, Hofman; A, Grobbee; DE, de Jong; P.T.","year":"1994","unstructured":"Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a populationbased study in The Netherlands. The Rotterdam Study. Ophthalmology 1994;101:1851-5.","journal-title":"The Rotterdam Study. Ophthalmology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0161-6420(96)30449-1","article-title":"Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study","volume":"103","year":"1996","unstructured":"Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103: 1661-9.","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bjo.77.1.17","article-title":"Prevalence of glaucoma in the west of Ireland","volume":"77","author":"Coffey, M.; Reidy, A.; Wormald, R.; Xian, W.X.; Wright, L.; Courtney, P.","year":"1993","unstructured":"Coffey M, Reidy A, Wormald R, Xian WX, Wright L, Courtney P. Prevalence of glaucoma in the west of Ireland. BrJ Ophthalmol 1993;77: 17-21.","journal-title":"BrJ Ophthalmol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1994.01090180121046","article-title":"The Barbados Eye Study. Prevalence of open angle glaucoma","volume":"112","author":"Leske, M.C.; Connell, A.M.; Schachat, A.P.; Hyman, L.","year":"1994","unstructured":"Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994;112: 821-9.","journal-title":"Arch Ophthalmol"},{"key":"ref_11","first-page":"339","article-title":"Clinical ophthalmology","author":"Kanski, J.J.","year":"1989","unstructured":"Kanski JJ. Clinical ophthalmology, 2nd edn. London: Butterworth Heinemann, 1989; pp 339-69.","edition":"2nd edn"},{"key":"ref_12","first-page":"23","article-title":"Therapeutic options in primary open-angle glaucoma","volume":"220","author":"Wishart, P.","year":"1997","unstructured":"Wishart P. Therapeutic options in primary open-angle glaucoma. Acta Ophthalmol Scand 1997;220(suppl):23-9.","journal-title":"Acta Ophthalmol Scand"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archopht.1995.01100030037018","article-title":"Aqueous flow in open-angle glaucoma","volume":"113","author":"Larsson, L.I.; Rettig, E.S.; Brubaker, R.F.","year":"1995","unstructured":"Larsson LI, Rettig ES, Brubaker RF. Aqueous flow in open-angle glaucoma. Arch Ophthalmol 1995;113:283-6.","journal-title":"Arch Ophthalmol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1755-3768.1993.tb08590.x","article-title":"Visual field prognosis in early glaucoma. A long-term clinical follow-up","volume":"71","author":"Odberg, T.","year":"1993","unstructured":"Odberg T. Visual field prognosis in early glaucoma. A long-term clinical follow-up. Acta Ophthalmol 1993;71:721-6.","journal-title":"Acta Ophthalmol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0002-9394(14)72724-2","article-title":"Incidence of acute angle-closure glaucoma after pharmacologic mydriasis","volume":"120","author":"Patel, K.H.; Javitt, J.C.; Tielsch, J.M.","year":"1995","unstructured":"Patel KH, Javitt JC, Tielsch JM, et al. Incidence of acute angle-closure glaucoma after pharmacologic mydriasis. Am J Ophthalmol 1995;120: 709-17.","journal-title":"Am J Ophthalmol"},{"key":"ref_16","first-page":"1","article-title":"Neuro-ophthalmology review manual 1988. Thorofare","author":"Bajandas, F.J.; Kline, L.B.","year":"1988","unstructured":"Bajandas FJ, Kline LB. Neuro-ophthalmology review manual 1988. Thorofare NJ: Slack Incorporated, 1988; pp 1-42."},{"key":"ref_17","first-page":"15","article-title":"Intraocular pressure and circulation at the disc in glaucoma","volume":"220","author":"Hitchings, R.A.","year":"1997","unstructured":"Hitchings RA. Intraocular pressure and circulation at the disc in glaucoma. Acta Ophthalmol Scand 1997;220(suppl): 15-22.","journal-title":"Acta Ophthalmol Scand"},{"key":"ref_18","first-page":"63","article-title":"Scanning laser Doppler flowmetry in glaucoma","volume":"20","author":"Hollo, G.; van den Berg, T.J.; Greve, E.L.","year":"1997","unstructured":"Hollo G, van den Berg TJ, Greve EL. Scanning laser Doppler flowmetry in glaucoma. Int Ophthalmol 1997;20:63-70.","journal-title":"Int Ophthalmol"},{"key":"ref_19","first-page":"690","article-title":"Color Doppler imaging in untreated highand normal-pressure open-angle glaucoma","volume":"38","author":"Butt, Z.; O'Brien, C.; McKillop, G.; Aspinall, P.; Allen, P.","year":"1997","unstructured":"Butt Z, O'Brien C, McKillop G, Aspinall P, Allen P. Color Doppler imaging in untreated highand normal-pressure open-angle glaucoma. Invest Ophthalmol Visual Sci 1997;38: 690-6.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-9394(14)70127-8","article-title":"Blood-flow velocities of the extraocular vessels in patients with high-tension and normaltension primary open-angle glaucoma","volume":"123","author":"Kaiser, H.J.; Schoetzau, A.; Stumpfig, D.; Flammer, J.","year":"1997","unstructured":"Kaiser HJ, Schoetzau A, Stumpfig D, Flammer J. Blood-flow velocities of the extraocular vessels in patients with high-tension and normaltension primary open-angle glaucoma. Am J Ophthalmol 1997;123:320-7.","journal-title":"Am J Ophthalmol"},{"key":"ref_21","first-page":"746","article-title":"Detection of disturbed autoregulation of the peripapillary choroid in primary open angle glaucoma","volume":"27","author":"Ulrich, A.; Ulrich, C.; Barth, T.; Ulrich, W.D.","year":"1996","unstructured":"Ulrich A, Ulrich C, Barth T, Ulrich WD. Detection of disturbed autoregulation of the peripapillary choroid in primary open angle glaucoma. Ophthalmic Surg Lasers 1996;27:746-57.","journal-title":"Ophthalmic Surg Lasers"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0039-6257(95)80002-6","article-title":"Newer visual function tests in the evaluation of glaucoma","volume":"40","author":"Stewart, W.C.; Chauhan, B.C.","year":"1995","unstructured":"Stewart WC, Chauhan BC. Newer visual function tests in the evaluation of glaucoma. Surv Ophthalmol 1995;40:119-35.","journal-title":"Surv Ophthalmol"},{"key":"ref_23","first-page":"441","article-title":"Automated perimetry in primary open-angle glaucoma","volume":"96","author":"Chen, Y.F.; Wang, T.H.; Hung, P.T.","year":"1997","unstructured":"Chen YF, Wang TH, Hung PT. Automated perimetry in primary open-angle glaucoma. J Formosan MedAssoc 1997;96:441-5.","journal-title":"J Formosan MedAssoc"},{"key":"ref_24","first-page":"2","article-title":"Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of shortterm studies with three dose regimens of latanoprost treatment","volume":"41","author":"Greve, E.L.; Rulo, A.H.; Drance, S.M.; Crichton, A.C.; Mills, R.P.; Hoyng, P.F.","year":"1997","unstructured":"Greve EL, Rulo AH, Drance SM, Crichton AC, Mills RP, Hoyng PF. Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of shortterm studies with three dose regimens of latanoprost treatment. Surv Ophthalmol 1997; 41(suppl 2):S89-92.","journal-title":"Surv Ophthalmol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0161-6420(96)30570-8","article-title":"Probable exclusion of GLC1A as a candidate glaucoma gene in a family with middle-ageonset primary open-angle glaucoma","volume":"103","author":"Richards, J.E.; Lichter, P.R.; Herman, S.","year":"1996","unstructured":"Richards JE, Lichter PR, Herman S, et al. Probable exclusion of GLC1A as a candidate glaucoma gene in a family with middle-ageonset primary open-angle glaucoma. Ophthalmology 1996;103: 1035-40.","journal-title":"Ophthalmology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9394(14)70147-3","article-title":"Juvenile glaucoma linked to the GLC1A gene on chromosome","volume":"123","author":"Lichter, P.R.; Richards, J.E.; Boehnke, M.","year":"1997","unstructured":"Lichter PR, Richards JE, Boehnke M, et al. Juvenile glaucoma linked to the GLC1A gene on chromosome 1 q in a Panamanian family. Am J Ophthalmol 1997;123:413-6.","journal-title":"Am J Ophthalmol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0161-6420(13)31615-7","article-title":"Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma","volume":"100","author":"Johnson, A.T.; Drack, A.V.; Kwitek, A.E.; Cannon, R.L.; Stone, E.M.; Alward, W.L.","year":"1993","unstructured":"Johnson AT, Drack AV, Kwitek AE, Cannon RL, Stone EM, Alward WL. Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma. Ophthalmology 1993;100:524-9.","journal-title":"Ophthalmology"},{"key":"ref_28","first-page":"79","article-title":"Genetic markers in primary open-angle glaucoma","volume":"20","author":"Abecia, E.; Martinez-Jarreta, B.; Casalod, Y.; Bell, B.; Pinilla, I.; Honrubia, F.M.","year":"1997","unstructured":"Abecia E, Martinez-Jarreta B, Casalod Y, Bell B, Pinilla I, Honrubia FM. Genetic markers in primary open-angle glaucoma. Int Ophthalmol 1997;20:79-82.","journal-title":"Int Ophthalmol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","article-title":"Adverse effects of topical antiglaucoma medication. The conjunctival cell profile","volume":"112","author":"Broadway, D.C.; Grierson, I.; O'Brien, C.; Hitchings, R.A.","year":"1994","unstructured":"Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. The conjunctival cell profile. Arch Ophthalmol 1994;112:1437-45.","journal-title":"Arch Ophthalmol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0161-6420(94)31120-1","article-title":"Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma","volume":"101","author":"Migdal, C.; Gregory, W.; Hitchings, R.","year":"1994","unstructured":"Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994;101:1651-7.","journal-title":"Ophthalmology"},{"key":"ref_31","first-page":"1009","article-title":"A doublemasked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol","volume":"113","author":"Strahlman, E.; Tipping, R.; Vogel, R.","year":"1995","unstructured":"Strahlman E, Tipping R, Vogel R, A doublemasked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. Arch Ophthalmol 1995;113:1009-16.","journal-title":"International Dorzolamide Study Group. Arch Ophthalmol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ageing\/25.6.424","article-title":"Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people","volume":"25","author":"Diggory, P.; Cassels-Brown, A.; Fernandez, C.","year":"1996","unstructured":"Diggory P, Cassels-Brown A, Fernandez C. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people. Age Ageing 1996;25:424-8.","journal-title":"Age Ageing"},{"key":"ref_33","first-page":"89","article-title":"Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine","volume":"94","author":"Robin, A.L.","year":"1996","unstructured":"Robin AL, Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine. Trans Am Ophthalmol Soc 1996;94:89-103.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archopht.1997.01100160017002","article-title":"A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group","volume":"115","author":"Schuman, J.S.; Horwitz, B.; Choplin, N.T.; David, R.; Albracht, D.; Chen, K.","year":"1997","unstructured":"Schuman JS, Horwitz B, Choplin NT, David R, Albracht D, Chen K. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group. Arch Ophthalmol 1997;115:847-52.","journal-title":"Arch Ophthalmol"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF00937283","article-title":"Efficacy of argon laser trabeculoplasty: 3-year preliminary results of a prospective placebo-controlled study","volume":"235","author":"Ustundag, C.; Diestelhorst, M.","year":"1997","unstructured":"Ustundag C, Diestelhorst M. Efficacy of argon laser trabeculoplasty: 3-year preliminary results of a prospective placebo-controlled study. Graefes Arch Clin Exp Ophthalmol 1997;235: 354-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3928\/1542-8877-19970201-08","article-title":"A review of the outcome of trabeculectomy in open-angle glaucoma","volume":"28","author":"Vesti, E.; Raitta, C.","year":"1997","unstructured":"Vesti E, Raitta C. A review of the outcome of trabeculectomy in open-angle glaucoma. Ophthalmic Surg Lasers 1997;28:128-32.","journal-title":"Ophthalmic Surg Lasers"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/eye.1995.58","article-title":"Intraocular pressure control following microtrabeculectomy","volume":"9","author":"Vernon, S.A.; Spencer, A.F.","year":"1995","unstructured":"Vernon SA, Spencer AF. Intraocular pressure control following microtrabeculectomy. Eye 1995;9:299-303.","journal-title":"Eye"},{"key":"ref_38","first-page":"4954","article-title":"Clinical evaluation of the effect of mitomycin-C in re-operation for primary open angle glaucoma","volume":"7","author":"Andreanos, D.; Georgopoulos, G.T.; Vergados, J.; Papaconstantinou, D.; Liokis, N.; Theodossiadis, P.","year":"1997","unstructured":"Andreanos D, Georgopoulos GT, Vergados J, Papaconstantinou D, Liokis N, Theodossiadis P. Clinical evaluation of the effect of mitomycin-C in re-operation for primary open angle glaucoma. Eur Jf Ophthalmol 1997;7:4954.","journal-title":"Eur Jf Ophthalmol"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.1997.01100160139001","article-title":"A long-term dose-response study of mitomycin in glaucoma filtration","volume":"115","author":"Robin, A.L.; Ramakrishnan, R.; Krishnadas, R.","year":"1997","unstructured":"Robin AL, Ramakrishnan R, Krishnadas R, et al. A long-term dose-response study of mitomycin in glaucoma filtration. Arch Ophthalmol 1997;115:969-74.","journal-title":"Arch Ophthalmol"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0161-6420(96)30508-3","article-title":"Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma","volume":"103","year":"1996","unstructured":"Kosoko 0, Gaasterland DE, Pollack IP, Enger CL. Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. Ophthalmology 1996;103: 1294-302.","journal-title":"Ophthalmology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0002-9394(14)70372-1","article-title":"Surgical vs medical management of chronic open-angle glaucoma","volume":"122","author":"Stewart, W.C.; Sine, C.S.; LoPresto, C.","year":"1996","unstructured":"Stewart WC, Sine CS, LoPresto C. Surgical vs medical management of chronic open-angle glaucoma. Am J Ophthalmol 1996;122:767-74.","journal-title":"Am J Ophthalmol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/74\/878\/709\/50222420\/postgradmedj-74-709.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/74\/878\/709\/50222420\/postgradmedj-74-709.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T06:44:29Z","timestamp":1684133069000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/74\/878\/709\/7062690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12,1]]},"references-count":41,"journal-issue":{"issue":"878","published-online":{"date-parts":[[1998,12,1]]},"published-print":{"date-parts":[[1998,12,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.74.878.709","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,12]]},"published":{"date-parts":[[1998,12,1]]}}}